Seiji Mabuchi - Gynecology

Author Information

Dr. Seiji Mabuchi is affiliated with the Department of Obstetrics and Gynecology at Osaka University Graduate School of Medicine, located in Suita, Osaka, Japan. His research primarily focuses on various aspects of gynecological cancers, including cervical, endometrial, and ovarian cancers. Dr. Mabuchi's work is renowned for its depth and impact in the field of gynecology.

Research Contributions

Dr. Seiji Mabuchi has made significant contributions to the field of gynecology through his extensive research on gynecological cancers. His recent studies address critical topics such as the management of recurrent cervical cancer, the clinical significance of systemic immune-inflammation indices in endometrial cancer, and innovative therapeutic targets for uterine cervical and endometrial cancers. Notably, his work also includes unique case reports, such as the first documented case of granulocyte colony-stimulating factor producing vulvar cancer and pioneering treatments for recurrent small cell neuroendocrine carcinoma of the uterine cervix.

Aliases

Dr. Seiji Mabuchi is also known by the following aliases: S Mabuchi, and S. Mabuchi.

Publication and Citation Metrics

Metric	Value
Citation Count	5854
H-index	42
Paper Count	244

Publications:

Iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy for recurrent cervical cancer: A case report and literature review

DOI: 10.1016/j.gore.2022.100938

Year: 2022

Primary Fallopian Tube Carcinoma Presenting with a Massive Inguinal Tumor: A Case Report and Literature Review

DOI: 10.3390/medicina58050581

Year: 2022

The first case of granulocyte colony-stimulating factor producing vulvar cancer.

DOI: 10.1080/01443615.2021.1978065

Year: 2022

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer

DOI: 10.1038/s41598-021-81298-1

Year: 2021

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers

DOI: 10.3390/cells10051073

Year: 2021

The first case of recurrent small cell neuroendocrine carcinoma of the uterine cervix successfully treated with robotic-assisted super radical hysterectomy

DOI: 10.1016/j.gore.2021.100882

Year: 2021

Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer

DOI: 10.1371/journal.pone.0248871

Year: 2021

The significance of post-radiotherapy parametrial involvement and the necessity of parametrial resection in locally-recurrent or persistent cervical cancer developed after radiotherapy.

DOI: 10.1016/j.jogoh.2021.102190

Year: 2021

Preclinical Activity of Plitidepsin Against Clear Cell Carcinoma of the Ovary

DOI: 10.21873/anticanres.15232

Year: 2021

Prognostic significance of tumor laterality in advanced ovarian cancer

DOI: 10.5468/ogs.21176

Year: 2021

What is Eplerenone?

How to Handle Out-of-Network Providers?

How is Fluid Resuscitation Administered?

What is a Cleft Palate?

How is ECG Performed?

Why is CAD Relevant in Gynecology?

How Often Should Milk Be Expressed?

What are the benefits of electronic medical records (EMRs) in gynecology?

What are ACOG's Main Functions?

What are Hormones in Gynecology?

Partnered Content Networks

Relevant Topics